Micro-Dosing Trend in Weight Loss Injections and Safety Debates

The micro-dosing trend spreading on social media, which involves using popular weight-loss injections below standard doses, is sparking debate among health authorities. Experts emphasize that this practice, done without medical supervision, carries serious safety risks.

Emergence of the Micro-Dosing Trend

In videos shared on social media, users state that they micro-dose to avoid side effects, reduce costs, or decrease food noise.

Some individuals who struggle with losing weight after menopause obtain medications like Ozempic over the internet and try using them in small amounts below the recommended standard doses.

Global Medication Usage Rates

According to World Health Organization data, approximately 100 million people worldwide use GLP-1 class medications, which increases interest in these drugs.

Experts' Safety Warnings

Experts emphasize that very little research has been conducted on the safety of the micro-dosing method, and the method has not yet been adequately studied in terms of safety and efficacy.

Clinical pharmacists point out that such unconscious practices can harbor various risks, such as incorrect dose calculations or contamination.

Views of Pharmaceutical Manufacturers and Doctors

Novo Nordisk, the manufacturer of Ozempic and Wegovy, and Eli Lilly, the manufacturer of Mounjaro, stated that they do not support any changes to the approved dosage instructions.

Doctors warn that all medication usage processes and potential dose adjustments must be carried out under the supervision of a specialist physician.